Locoregional delivery of stem cell-based therapies.

Science Translational Medicine
Nathan Norton Ng, Avnesh Sinh Thakor

Abstract

Interventional regenerative medicine (IRM) uses image-guided, minimally invasive procedures for the targeted delivery of stem cell-based therapies to regenerate, replace, or repair damaged organs. Although many cellular therapies have shown promise in the preclinical setting, clinical results have been suboptimal. Most intravenously delivered cells become trapped in the lungs and reticuloendothelial system, resulting in little therapy reaching target tissues. IRM aims to increase the efficacy of cell-based therapies by locoregional stem cell delivery via endovascular, endoluminal, or direct injection into tissues. This review highlights routes of delivery, disease states, and mechanisms of action involved in the targeted delivery of stem cells.

References

Sep 25, 2003·Cell·Antonio P BeltramiPiero Anversa
Oct 9, 2004·Circulation Research·Elisa MessinaAlessandro Giacomello
Mar 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Buddhadeb DawnRoberto Bolli
Nov 25, 2005·Stem Cells and Development·Martina VendrameAlison E Willing
Apr 1, 2006·Circulation Research·Kaoru TatenoIssei Komuro
Apr 11, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Masaya TakahashiKimikazu Hamano
Sep 23, 2006·The New England Journal of Medicine·Ketil LundeKolbjørn Forfang
Jan 26, 2007·Proceedings of the National Academy of Sciences of the United States of America·Maria MirotsouVictor Dzau
Sep 18, 2007·Biochemical and Biophysical Research Communications·Biju ParekkadanMartin L Yarmush
Dec 25, 2007·Brain : a Journal of Neurology·Soon-Tae LeeJae-Kyu Roh
May 16, 2008·American Journal of Physiology. Renal Physiology·Florian TögelChristof Westenfelder
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hirokazu OhtakiDarwin J Prockop
Oct 14, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Troy A MarkelDaniel R Meldrum
Oct 1, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Jing WangRobert Chunhua Zhao
Mar 30, 2010·Journal of Vascular and Interventional Radiology : JVIR·Augusto BrazziniLuis N Saenz
Oct 30, 2010·Journal of Vascular Surgery·Holger LawallBerthold Amann
May 14, 2011·Stroke; a Journal of Cerebral Circulation·Yu-Ching LinYu-Show Fu
Aug 4, 2011·Nuclear Medicine and Biology·Ali GholamrezanezhadReza Malekzadeh
Nov 16, 2011·JAMA : the Journal of the American Medical Association·Jay H TraverseUNKNOWN Cardiovascular Cell Therapy ResearchNetwork
Dec 14, 2011·The Journal of Biological Chemistry·Derrick D RoweKeith R Pennypacker
Dec 30, 2011·American Journal of Physiology. Renal Physiology·Jin Hyun KimSe-Ho Chang
Mar 17, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jun LiLanjuan Li
Apr 5, 2012·American Journal of Nephrology·Henry E WangDavid G Warnock
Jun 1, 2012·Journal of Cardiovascular Translational Research·Niall G Campbell, Ken Suzuki

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
M I NasserPing Zhu
Current Stem Cell Research & Therapy
Mihai Bogdan Preda, Guro Valen
Journal of Materials Chemistry. B, Materials for Biology and Medicine
L M RiclesL J Suggs
Current Opinion in Biotechnology
Michael SittingerMakarand V Risbud
© 2022 Meta ULC. All rights reserved